Over the past decade, the therapeutic potential of nanomaterials as novel drug delivery
systems complementing conventional pharmacology has been widely acknowledged …

Abstract mRNA vaccines have won the race for early COVID-19 vaccine approval, yet
improvements are necessary to retain this leading role in combating infectious diseases. A …

In the design of vaccine generation, significant attempts have been made to produce novel
vaccines and, as well, to increase the effectiveness of available vaccines versus particular …

Biosynthesis of metallic silver nanoparticles (AgNPs) has gained much interest and offers an
attractive alternate to physical and chemical approaches. In recent year several safe, easy …

Wound healing primarily involves preventing severe infections, accelerating healing, and
reducing pain and scarring. Therefore, the multifunctional application of lipid-based …

The use of biomaterials in delivering CRISPR/Cas9 for gene therapy in infectious diseases
holds tremendous potential. This innovative approach combines the advantages of …

The lipid-based colloidal carriers, such as nanostructured lipid carriers (NLCs), solid lipid
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …

The use of natural compounds is becoming increasingly popular among patients, and there
is a renewed interest among scientists in nature-based bioactive agents. Traditionally …

Fluorescent organic nanoparticles (FONs) are a large family of nanostructures constituted by
organic components that emit light in different spectral regions upon excitation, due to the …

Active pharmaceutical ingredients (API) or drugs are normally not delivered as pure
chemical substances (for the prevention or the treatment of any diseases). APIs are still …